Kitty Slieker

738 total citations · 1 hit paper
8 papers, 160 citations indexed

About

Kitty Slieker is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Kitty Slieker has authored 8 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Kitty Slieker's work include Long-Term Effects of COVID-19 (4 papers), COVID-19 Clinical Research Studies (3 papers) and COVID-19 and Mental Health (2 papers). Kitty Slieker is often cited by papers focused on Long-Term Effects of COVID-19 (4 papers), COVID-19 Clinical Research Studies (3 papers) and COVID-19 and Mental Health (2 papers). Kitty Slieker collaborates with scholars based in Netherlands, Australia and Germany. Kitty Slieker's co-authors include Chantal P. Bleeker‐Rovers, Jaap ten Oever, Pythia T. Nieuwkerk, Annemarie Braamse, Stephan P. Keijmel, Fabiola Müller, Michèle van Vugt, Richard Kanaan, Tim olde Hartman and Hans Knoop and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Nuclear Medicine.

In The Last Decade

Kitty Slieker

6 papers receiving 155 citations

Hit Papers

Efficacy of Cognitive-Behavioral Therapy Targeting Severe... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kitty Slieker Netherlands 5 87 47 46 37 29 8 160
Mohammad Mobin Teymouri Athar Iran 8 59 0.7× 23 0.5× 40 0.9× 43 1.2× 29 1.0× 18 193
Paul Kuodi Israel 8 113 1.3× 23 0.5× 67 1.5× 72 1.9× 27 0.9× 21 228
Yolanda Ruíz Spain 6 90 1.0× 26 0.6× 39 0.8× 54 1.5× 14 0.5× 16 155
Sisira Yadala United States 6 172 2.0× 25 0.5× 97 2.1× 99 2.7× 17 0.6× 16 279
Tomoya Tsuchida Japan 8 104 1.2× 12 0.3× 34 0.7× 76 2.1× 15 0.5× 27 192
Immo Weichert United Kingdom 6 86 1.0× 14 0.3× 24 0.5× 54 1.5× 16 0.6× 11 196
Nathalie MacDermott United Kingdom 5 159 1.8× 46 1.0× 64 1.4× 66 1.8× 15 0.5× 9 217
Esther Moreno Spain 4 132 1.5× 27 0.6× 77 1.7× 36 1.0× 26 0.9× 8 178
Jennifer Camaradou United Kingdom 5 59 0.7× 16 0.3× 41 0.9× 19 0.5× 5 0.2× 7 163
Nikki Nabavi United Kingdom 4 166 1.9× 39 0.8× 80 1.7× 83 2.2× 8 0.3× 14 235

Countries citing papers authored by Kitty Slieker

Since Specialization
Citations

This map shows the geographic impact of Kitty Slieker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kitty Slieker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kitty Slieker more than expected).

Fields of papers citing papers by Kitty Slieker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kitty Slieker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kitty Slieker. The network helps show where Kitty Slieker may publish in the future.

Co-authorship network of co-authors of Kitty Slieker

This figure shows the co-authorship network connecting the top 25 collaborators of Kitty Slieker. A scholar is included among the top collaborators of Kitty Slieker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kitty Slieker. Kitty Slieker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bizzarri, Daniele, Simon P. Mooijaart, Angèle P. M. Kerckhoffs, et al.. (2025). Associations between metabolomic scores and clinical outcomes in hospitalized COVID-19 patients. GeroScience. 47(3). 4395–4411.
2.
Oerlemans, Anke, Heidi Ammerlaan, Kitty Slieker, et al.. (2025). From losing control to regaining control: Patient experiences of care for Staphylococcus aureus bacteremia. Patient Education and Counseling. 139. 109255–109255.
3.
Berrevoets, Marvin A. H., Emma de Jong, Heidi Ammerlaan, et al.. (2024). Low-Risk Staphylococcus aureus Bacteremia Patients Do Not Require Routine Diagnostic Imaging: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 79(1). 43–51. 3 indexed citations
4.
Müller, Fabiola, Annemarie Braamse, Brent Appelman, et al.. (2023). Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clinical Infectious Diseases. 77(5). 687–695. 70 indexed citations breakdown →
5.
Maat, Josephine van de, Karin Veerman, Jaap ten Oever, et al.. (2021). Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study. PLoS ONE. 16(3). e0248713–e0248713. 27 indexed citations
6.
7.
Slieker, Kitty, et al.. (2020). [COVID-19 in the Emergency Department of Bernhoven hospital].. PubMed. 164. 11 indexed citations
8.
Berrevoets, Marvin A. H., Ilse J.E. Kouijzer, Kitty Slieker, et al.. (2018). 18F-FDG PET/CT–Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle. Journal of Nuclear Medicine. 60(7). 998–1002. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026